ImClone Systems

ImClone Systems was a company operating in the pharmaceutical industry, technology, biology, and biotechnology sectors. The company, founded on January 1, 1984, was headquartered in New York, with its legal name registered as ImClone Systems International GmbH. ImClone Systems was incorporated in Delaware and had the stock symbol IMCL.

ImClone Systems was assigned one patent during its time of operation and held a SIC code of 2836. The company's CIK number was 765258, and its IRS number was 42834797. ImClone Systems was acquired by Eli Lilly and Company, subsequently becoming a part of the parent organization. Following this acquisition, ImClone Systems was closed down as a separate entity.